ClinicalTrials.Veeva

Menu
Universal Axon Clinical Research, LLC | Doral, FL logo

Universal Axon Clinical Research, LLC | Doral, FL

Research site

Site insights

Top conditions

Top treatments

Upadacitinib
ABT-494
Risankizumab
fezolinetant
ALN-CIDEB
Enobosarm
Ozanimod
VERU-111
HP-211
Berobenatide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Albert Garcia

Verified by this site

Active trials

16 of 48 total trials

A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

This is a longitudinal follow-up study of the RC-002 study, in which up to 246 subjects assigned to two randomization arms will be enrolled: an adipo...

Invitation-only
Partial Thickness Rotator Cuff Tear
Device: Adipose Derived Regenerative Cells
Device: Corticosteroid

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: Placebo
Drug: Upadacitinib (ABT-494)

This is a multicenter, randomized, double-blind, factorial design Phase 2 study to evaluate the pharmacodynamics, safety and tolerability of a combin...

Enrolling
Hypercholesterolaemia
Drug: Inclisiran placebo
Drug: QCZ484 placebo

The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Active, not recruiting
Acute Gastroenteritis
Norovirus Acute Gastroenteritis
Biological: mRNA-1403
Biological: Placebo

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in t...

Enrolling
COVID-19 SARS-CoV-2 Infection
Drug: placebo
Drug: ibuzatrelvir

The purpose of this clinical study is to learn about the safety and effects of berobenatide (PF-08653944) for the treatment of knee osteoarthritis in...

Enrolling
Overweight
Osteoarthritis of the Knee
Drug: Berobenatide
Other: Placebo

The purpose of this investigation is to evaluate the safety and superior effectiveness in functional improvement in patients with partial-thickness r...

Active, not recruiting
Rotator Cuff Tear
Rotator Cuff Tendinitis
Device: Adipose Derived Regenerative Cells
Drug: Corticosteroid

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which...

Enrolling
Type 2 Diabetes
Drug: HP-211
Drug: Placebo

This is a phase 2, double-blind, randomized, placebo-controlled, multi-center, dose-finding study to evaluate the efficacy and safety of Kylo-11 admi...

Active, not recruiting
Lipoprotein Disorder
Drug: Kylo-11 or matched placebo

The primary objective of this study is to assess the effect of enobosarm on total body weight

Active, not recruiting
Obesity & Overweight
Mobility Disability
Drug: Semaglutide (Wegovy) weekly injection
Drug: Enobosarm

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Active, not recruiting
Endometriosis
Drug: Elagolix
Drug: Placebo
Locations recently updated

This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease called MASH.In this study, researc...

Enrolling
MASH
Metabolic Dysfunction-Associated Steatohepatitis
Drug: Placebo
Drug: ALN-CIDEB

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

Trial sponsors

AbbVie logo
Pfizer logo
Veru logo
Astellas logo
BioNTech logo
Celgene logo
F
I
Moderna logo
Novartis logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems